Pancreatic ductal adenocarcinoma (PDAC) is the most common and lethal form of
pancreatic cancer, with a survival approaching only 11% at five years after diagnosis. In the …

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal and common form of
pancreatic cancer, it has no specific symptoms, and most of the patients are diagnosed …

Introduction Pancreatic ductal adenocarcinoma (PDAC) is lethal due to its late diagnosis
and lack of successful treatments. A possible strategy to reduce its death burden is …

Background The current knowledge on pancreatic ductal adenocarcinoma (PDAC) risk
factors is limited and no study has comprehensively tested the exposome in combination …

Coding sequence variants comprise a small fraction of the germline genetic variability of the
human genome. However, they often cause deleterious change in protein function and are …

Background Predicting the risk of developing pancreatic ductal adenocarcinoma (PDAC) is
of paramount importance, given its high mortality rate. Current PDAC risk prediction models …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with patients
having unresectable or metastatic disease at diagnosis, with poor prognosis and very short …

Pancreatic cancer is currently the seventh leading cause of cancer death worldwide.
Understanding whether modifiable factors increase or decrease the risk of this disease is …

Background The genomes of present-day non-Africans are composed of 1–3% of
Neandertal-derived DNA as a consequence of admixture events between Neandertals and …

Pancreatic cancer (PC) ranks as the seventh leading cause of cancer-related deaths, with
approximately 500,000 new cases reported in 2020. Existing strategies for early PC …